The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle

Authors

Wei Du (ORCID: https://orcid.org/0000-0001-9974-9668)
Rong Xu (ORCID: https://orcid.org/0000-0001-5465-3566)
Yong Xu (ORCID: https://orcid.org/0000-0001-7439-7141)
Hailong Li (ORCID: https://orcid.org/0009-0007-9767-0877)

Institutions

Central South University (CN)
The First People's Hospital of Changde (CN)

Publication Details

Journal: BMC Cancer
Published: 2024-09-09
DOI: https://doi.org/10.1186/s12885-024-12879-2
Primary Topic: Epigenetics and DNA Methylation
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle

Wei Du, Rong Xu, Yong Xu, Hailong Li

Sep 9, 2024

BMC Cancer

Epigenetics and DNA Methylation

article

The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle

Wei Du, Rong Xu, Yong Xu, Hailong Li

September 9, 2024article en

Abstract

No abstract available for this paper.

BMC CancerVol. 24(1)

Central South University (CN), The First People's Hospital of Changde (CN)

Good health and well-being

Openalex Percentile: Top 87%

Epigenetics and DNA Methylation

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle — Wei Du, Rong Xu, et al. · BMC Cancer (2024) | TGRS Research Map | TGRS